Delayed gastric emptying in critical illness: is enhanced enterogastric inhibition with cholecystokinin and peptide YY involved?
- PMID: 18448925
- PMCID: PMC7152226
- DOI: 10.1097/CCM.0b013e318170157b
Delayed gastric emptying in critical illness: is enhanced enterogastric inhibition with cholecystokinin and peptide YY involved?
Comment on
-
The impact of delaying enteral feeding on gastric emptying, plasma cholecystokinin, and peptide YY concentrations in critically ill patients.Crit Care Med. 2008 May;36(5):1469-74. doi: 10.1097/CCM.0b013e31816fc457. Crit Care Med. 2008. PMID: 18434906 Clinical Trial.
Similar articles
-
The impact of delaying enteral feeding on gastric emptying, plasma cholecystokinin, and peptide YY concentrations in critically ill patients.Crit Care Med. 2008 May;36(5):1469-74. doi: 10.1097/CCM.0b013e31816fc457. Crit Care Med. 2008. PMID: 18434906 Clinical Trial.
-
The relationship between gastric emptying, plasma cholecystokinin, and peptide YY in critically ill patients.Crit Care. 2007;11(6):R132. doi: 10.1186/cc6205. Crit Care. 2007. PMID: 18154642 Free PMC article.
-
Intestinal fat-induced inhibition of meal-stimulated gastric acid secretion depends on CCK but not peptide YY.Am J Physiol. 1999 Feb;276(2):G550-5. doi: 10.1152/ajpgi.1999.276.2.G550. Am J Physiol. 1999. PMID: 9950830
-
Gastrointestinal hormonal dysfunction in gastroparesis and functional dyspepsia.Neurogastroenterol Motil. 2010 Dec;22(12):1270-8. doi: 10.1111/j.1365-2982.2010.01609.x. Epub 2010 Oct 5. Neurogastroenterol Motil. 2010. PMID: 20939851 Review.
-
Why does cholecystokinin increase in critically ill patients?Crit Care Med. 2007 Jan;35(1):298-9. doi: 10.1097/01.CCM.0000251359.33232.1D. Crit Care Med. 2007. PMID: 17197772 Review. No abstract available.
References
-
- U.S. Department of Health and Human Services, Food and Drug Administration . The Code of Federal Regulations, 21 CFR Parts 600, 606, 640. U.S. Government Printing Office; Washington, DC: 1999.
-
- Standards for Blood Banks and Transfusion Services. 21st ed. American Association of Blood Banks; Bethesda, MD: 2002.
-
- Starkey JM, Mactherson JL, Bolgiano DC. Markers for transfusion-transmitted disease in different groups of blood donors. JAMA. 1989;262:3452–3454. - PubMed
-
- Whyte G, Coghlan P. Comparative safety of units donated by autologous, designated and allogeneic (homologous) donors. Transfus Med. 1996;6:209–211. - PubMed
-
- Page PL. Directed blood donations: Con. Transfusion. 1989;29:65–69. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources